Fenretinide in Treating Patients With Cervical Neoplasia
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention uses drugs to try and prevent development of cancer. Fenretinide
may be effective in treating cervical neoplasia and preventing cervical cancer.
PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of
fenretinide to placebo in treating patients with cervical neoplasia.